- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT00076622
Medication Treatment for Depression in Nursing Home Residents
Drug Treatment of Depression in the Nursing Home Aged
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
There are approximately 1.6 million nursing home residents in the United States. More than one third of these residents are taking antidepressant medications (ADs). Although ADs are effective, evidence suggests that they can lead to significant adverse events, including an increased risk of falls and bone fractures. Many depressed nursing home residents suffer from an initial episode of late-life depression and do not meet guideline-based recommendations for maintenance treatment. This study will examine the benefits and risks of long-term AD treatment in depressed nursing home residents whose single episode of depression has been in continuous remission for at least six months.
Participants will be randomly assigned to either continue or discontinue AD treatment. Participants will be monitored over a period of one year for recurrence of depression and related symptoms, as well as for the occurrence of falls, fractures, and other adverse events. Medical chart review, self-reported mood symptoms, and depression scales will be used to assess participants.
Studietype
Registrering (Faktiske)
Kontakter og plasseringer
Studiesteder
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Forente stater, 19104
- University of Pennsylvania
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
Beskrivelse
Inclusion Criteria:
- Current use of antidepressant medication
- Have been in remission from first episode of depression for 6 months or longer
- Currently residing in a long term care or assisted living facility
Exclusion Criteria:
- Bedridden
- Severe cognitive impairment
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Kohorter og intervensjoner
Gruppe / Kohort |
Intervensjon / Behandling |
---|---|
Randomized to drug continuation
Participants assigned to continue current antidepressant medication
|
Participants assigned to continue current medication will be monitored over a period of one year for recurrence of depression and related symptoms.
|
Randomized to drug discontinuation
Participants assigned to discontinue current antidepressant medication (no antidepressant medication)
|
Participants assigned to discontinue current medication (no antidepressant medication) will be monitored over a period of one year for recurrence of depression and related symptoms.
|
Participant preference to continue drug
Chose to continue antidepressant medication
|
Participants assigned to continue current medication will be monitored over a period of one year for recurrence of depression and related symptoms.
|
Participant preference to discontinue drug
Chose to discontinue antidepressant medication (no antidepressant medication)
|
Participants assigned to discontinue current medication (no antidepressant medication) will be monitored over a period of one year for recurrence of depression and related symptoms.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Geriatric Depression Scale (GDS) Score
Tidsramme: Measured at Month 12
|
The GDS scale measures presence and severity of depressive symptoms in older adults.
Scores range from zero (no depression symptoms) to thirty (severe depression symptoms).
|
Measured at Month 12
|
Number of Falls Experienced by Participants Over Twelve Months of Surveillance
Tidsramme: Measured from Baseline through Month Twelve
|
Measured from Baseline through Month Twelve
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Cognitive Function (MMSE)
Tidsramme: Measured at Month 12
|
The Mini Mental State Examination (MMSE) measures cognitive function in multiple domains, including memory, orientation, language, and executive function.
Scores range from zero (severe cognitive impairment) to thirty (intact cognitive function).
|
Measured at Month 12
|
Samarbeidspartnere og etterforskere
Sponsor
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: Joel E. Streim, MD, University of Pennsylvania
Publikasjoner og nyttige lenker
Generelle publikasjoner
- Streim JE, DiFilippo S, TenHave T, Mavandadi S, Weintraub D, Oslin D. Antidepressant discontinuation associated with cognitive decline in older adult residents of long-term care facilities. Am J Geriatr Psychiatry 20(3) (supplement 1): S147-148, 2012.
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- R37MH051247 (U.S. NIH-stipend/kontrakt)
- DSIR AT-GP
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Antidepressant medication
-
Taliaz Ltd.Ukjent
-
University of North Carolina, Chapel HillMedical University of South Carolina; National Institute of Mental Health... og andre samarbeidspartnereFullførtHIV/AIDS | Medisinoverholdelse | Hiv | Seksuell atferd | Seksuelt overførbare infeksjoner (ikke HIV eller hepatitt)Forente stater
-
Fundació Sant Joan de DéuParc Sanitari Sant Joan de Déu; Institut Català de la Salut; Jordi Gol i... og andre samarbeidspartnereAktiv, ikke rekrutterendeOverholdelse, medisineringSpania
-
PHCC LPNational Heart, Lung, and Blood Institute (NHLBI)FullførtKardiovaskulære sykdommerForente stater
-
University Hospital, ToulouseRekrutteringLupus erythematosusFrankrike
-
University of PittsburghTilbaketrukketMedisinoverholdelse | Bivirkning på medikament | Medisinering ikke-overholdelseForente stater
-
Korea University Guro HospitalUkjentSchizofreni | Schizoaffektiv lidelseKorea, Republikken
-
Fundació Sant Joan de DéuParc Sanitari Sant Joan de Déu; Institut Català de la Salut; Jordi Gol i... og andre samarbeidspartnereFullførtOverholdelse, medisineringSpania
-
BiogenAvsluttet
-
Cari Health Inc.Har ikke rekruttert ennåOverholdelse, medisinering | Opioidbruksforstyrrelse